Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

Open access
Martinez-Lopez, Joaquin, Lahuerta, Juan J., Pepin, François, González, Marcos, Barrio, Santiago, Ayala, Rosa, Puig, Noemí, Montalban, María A., Paiva, Bruno, Weng, Li, Jiménez, Cristina, Sopena, María, Moorhead, Martin, Cedena, Teresa, Rapado, Immaculada, Mateos, María Victoria, Rosiñol, Laura, Oriol, Albert, Blanchard, María J., Martínez, Rafael, Bladé, Joan, San Miguel, Jesús, Faham, Malek, García-Sanz, Ramón · 2014 · Blood

Abstract

Key Points: MRD assessment by sequencing is prognostic of TTP and OS in multiple myeloma patients. Among patients in complete response, MRD assessment by sequencing enables identification of 2 distinct subgroups with different TTP.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2014-01-550020

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Cited by

See all 425

Metadata

Authors
Martinez-Lopez, J., Lahuerta, J. J., Pepin, F., González, M., Barrio, S., Ayala, R., Puig, N., Montalban, M. A., Paiva, B., Weng, L., Jiménez, C., Sopena, M., Moorhead, M., Cedena, T., Rapado, I., Mateos, M. V., Rosiñol, L., Oriol, A., Blanchard, M. J., Martínez, R., Bladé, J., San Miguel, J., Faham, M., & García-Sanz, R.
Affiliations
  • Hospital Universitario 12 de Octubre, Madrid, Spain;
  • Hospital Universitario 12 De Octubre (ES)
  • Sequenta, Inc., San Francisco, CA;
  • Consejo Superior de Investigaciones Científicas (ES)
  • Clinica Universidad de Navarra (ES)
  • Hospital Clínic de Barcelona (ES)
  • Hospital Universitari Germans Trias i Pujol (ES)
  • Hospital Universitario Ramón y Cajal (ES)
  • Hospital Clínico de Madrid, Madrid, Spain
  • Clínica Universitaria de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain;
  • Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain;
Venue
Blood
Published
2014-05-15
Volume
123
Issue
20
Pages
3073-3079
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2086595383
Cited by
425
References
52
Citations by year
2026: 8 · 2025: 13 · 2024: 16 · 2023: 17 · 2022: 29 · 2021: 40 · 2020: 51 · 2019: 49 · 2018: 43 · 2017: 59 · 2016: 37 · 2015: 43 · 2014: 16
FWCI
36.65
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Gredos (University of Salamanca) (publishedVersion, public-domain)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Hispana (submittedVersion, public-domain)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
Keywords
multiple myeloma, minimal residual disease, deep sequencing, prognostic value, multiparameter flow cytometry, allele-specific oligonucleotide PCR, time to progression, overall survival, very good partial response, complete response
MeSH terms
Adult, Aged, Aged, 80 and over, Bone Marrow, Female, Humans, Male, Middle Aged, Multiple Myeloma, Prognosis, Cohort Studies, Neoplasm, Residual, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma. https://app.cochat.ai/papers/10.1182/blood-2014-01-550020
The paper
Martinez-Lopez, J., Lahuerta, J. J., Pepin, F., González, M., Barrio, S., Ayala, R., Puig, N., Montalban, M. A., Paiva, B., Weng, L., Jiménez, C., Sopena, M., Moorhead, M., Cedena, T., Rapado, I., Mateos, M. V., Rosiñol, L., Oriol, A., Blanchard, M. J., . . . García-Sanz, R. (2014). Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma. Blood. https://doi.org/10.1182/blood-2014-01-550020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.